Skip to content

Comprehensive Reverse Shoulder 115330

by Biomet Orthopedics, Inc.

Comprehensive Reverse Shoulder 115330 is a reverse shoulder prosthesis body (FDA Class II) made by Biomet Orthopedics, Inc., cleared under FDA 510(k) K193373 on 15 Apr 2020 (3 earlier submissions) and listed in FDA GUDID since 24 Oct 2015 (UDI-DI 00880304475342), active as of 23 Oct 2026. 22 FDA recalls are linked to it.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

24 closed

Documents

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK193373 Date15 Apr 2020DecidedStatusActive
United StatesGUDID listing Number00880304475342 UDI-DI Date24 Oct 2015ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Across registries

2 registries list this device

  • FDA 510(k) K193373 decided 15 Apr 2020 Active· +3 more in the status table
  • FDA GUDID UDI-DI 00880304475342 listed 24 Oct 2015 Listed

Recalls

24 recalls · FDA

    • Terminated Z-0619-2021 FDA Class II initiated 25 Nov 2020

    Specific lots of multiple sterile medical devices may have a breach in the sterile seal. A breach in the packaging seal could lead to loss of sterility of the device.

    • Terminated Z-0093-2021 FDA Class II initiated 2 Sep 2020

    Product potentially being packaged without a taper adapter or baseplate. The package should contain one (1) baseplate and one (1) taper adapter, product may be packaged with two (2) baseplates and no (0) adapters or with no (0) baseplates and two (2) adapters

    • Terminated Z-2144-2020 FDA Class II initiated 17 Apr 2020

    Potential presence of elevated endotoxin levels that exceed the specification limit

    • Terminated Z-1750-2020 FDA Class II initiated 13 Mar 2020

    There were unknown bioburden levels prior to sterilization, which may affect sterility of the product.

    • Terminated Z-1615-2020 FDA Class II initiated 25 Feb 2020

    Package is intended to contain one (1) baseplate and one (1) taper adapter; however, devices may be packaged with two (2) baseplates and no (0) adapters.

    • Terminated Z-0528-2020 FDA Class II initiated 21 Aug 2019 on shared 510(k) K992367

    Elevated levels of bacterial endotoxin and residual debris remain on the devices due to cleaning issue.

    • Terminated Z-0972-2019 FDA Class II initiated 21 Dec 2018

    The product was potentially being packaged without a taper adapter.

    • Terminated Z-1859-2017 FDA Class II initiated 17 Feb 2017

    Endotoxin levels higher than process maximum limits were discovered in the identified polyethylene components.

    • Terminated Z-1103-2017 FDA Class I initiated 20 Dec 2016

    Higher than anticipated rate of fracturing due to design. Risk of revision surgery due to fracturing.

    • Terminated Z-1823-2016 FDA Class II initiated 1 Apr 2016 on shared 510(k) K992367

    Insufficient seal strength on sterile barrier packaging. The seal could be jeopardized causing the sterile barrier to be compromised and the product could become nonsterile. If the product becomes non-sterile and is used or implanted, it may lead to an infection.

    • Terminated Z-1208-2015 FDA Class II initiated 7 Jan 2015

    The taper adaptor is missing from the packaging, which may result in a delay in surgery greater than 30 minutes.

    • Terminated Z-1548-2013 FDA Class II initiated 15 May 2013

    Biomet has initiated this action following an investigation which identified that the slot on the resection guide is offset in the wrong direction. When the slot on the resection guide is offset in the wrong direction, the Steinman pin that is intended to hold the guide into place may not come into contact with the bone.

  • 10 recalls, same reason

    • Terminated Z-2548-2011 FDA Unclassified (pre-2012) initiated 22 Apr 2011
    • Terminated Z-2547-2011 FDA Unclassified (pre-2012) initiated 22 Apr 2011
    • Terminated Z-2550-2011 FDA Unclassified (pre-2012) initiated 22 Apr 2011
    • Terminated Z-2546-2011 FDA Unclassified (pre-2012) initiated 22 Apr 2011
    • Terminated Z-2542-2011 FDA Unclassified (pre-2012) initiated 22 Apr 2011
    • Terminated Z-2545-2011 FDA Unclassified (pre-2012) initiated 22 Apr 2011
    • Terminated Z-2541-2011 FDA Unclassified (pre-2012) initiated 22 Apr 2011
    • Terminated Z-2549-2011 FDA Unclassified (pre-2012) initiated 22 Apr 2011
    • Terminated Z-2544-2011 FDA Unclassified (pre-2012) initiated 22 Apr 2011
    • Terminated Z-2543-2011 FDA Unclassified (pre-2012) initiated 22 Apr 2011

    The firm is initiating this recall following an investigation which identified the rare possibility that certain units of Comprehensive Reverse Shoulder Humeral Trays may contain a locking ring that is incorrectly assembled.

  • 2 recalls, same reason

    • Terminated Z-0712-2011 FDA Unclassified (pre-2012) initiated 13 Sep 2010
    • Terminated Z-0713-2011 FDA Unclassified (pre-2012) initiated 13 Sep 2010

    The firm received complaints regarding fracturing of the device.

Recalls on a shared submission name another device cleared under the same FDA submission as this one.

Timeline

29 dated events

  1. Recall initiated FDA recalls Z-1103-2017
  2. Recall initiated FDA recalls Z-1859-2017
  3. Recall initiated FDA recalls Z-0972-2019
  4. Recall initiated FDA recalls Z-0528-2020
  5. Recall initiated FDA recalls Z-1615-2020
  6. Recall initiated FDA recalls Z-1750-2020
  7. Cleared FDA 510(k) K193373
  8. Recall initiated FDA recalls Z-2144-2020
  9. Recall initiated FDA recalls Z-0093-2021
  10. Recall initiated FDA recalls Z-0619-2021

19 earlier events are in the sections above.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
Comprehensive Reverse Shoulder
Generic name
Reverse shoulder prosthesis body
Model / Ref / Catalog
115330
Primary DI / UDI-DI
00880304475342
FDA product code
PHX, KWS, PAO
GMDN term
Reverse shoulder prosthesis body
Device class
Class II
Regulation number
888.3660
GUDID distribution status
In Commercial Distribution

Similar devices in this category

Other devices filed under Reverse shoulder prosthesis body.

Other devices from Biomet Orthopedics, Inc.

See all devices from Biomet Orthopedics, Inc. →

Properties

  • Supplied sterile
  • Single use
  • Implantable
  • Prescription use
  • Lot / batch number
  • Expiration date
Other properties (9, all answered No)